News

Neurocrine Biosciences to Spotlight Its Scientific Journey and Growing Neuropsychiatry Pipeline at 2026 NEI Fall Congress

SAN DIEGO, Nov. 3, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its participation in the 2026 Neuroscience Education Institute (NEI) Fall Congress, taking place Nov. 5-8 in Colorado Springs, Colo. Through a […]


ADVERTISEMENT — Advertise With Biotech Networks
News

TCT26: Medtronic Symplicity blood pressure procedure shows significant blood pressure drops in SPYRAL AFFIRM real-world study

Nearly nine out of 10 patients experienced a clinical benefit at six months Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options GALWAY, Ireland and […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ELUCIDATE Study Demonstrates 93 Percent Accuracy with Strong Performance in the “Gray Zone” for Elucid’s FDA-cleared FFR-IQ™

BOSTON & SAN DIEGO–(BUSINESS WIRE)– #CCTA–Elucid, an innovator of AI-powered cardiovascular imaging software, today announced results from ELUCIDATE, presented at the annual Transcatheter Cardiovascular Therapeutics Conference (TCT 2026). The ELUCIDATE study, which supported Elucid’s recent […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
San Diego Biotech Jobs

Lab Automation Scientist – La Jolla, CA

Spectrix Analytical Services is recruiting an Associate Laboratory Automation Scientist to be placed in an Innovative Medicine Discovery Technologies… Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints

Both post-implant monotherapies in the trial achieved non-inferiority compared to dual anti-platelet therapy (DAPT) supporting the potential to simplify post-procedure drug regimens MARLBOROUGH, Mass. and SAN DIEGO, Nov. 2, 2026 /PRNewswire/ — Boston Scientific Corporation […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Paulex Bio Announces Registration of Phase 1/2a Trial of PAL-119, an Oral Small Molecule Designed to Regenerate and Restore the Function of Insulin-Producing Beta Cells

First-in-human study plans to enroll healthy volunteers and adults with Type 1 or Type 2 diabetes to evaluate PAL-119’s safety and tolerability and explore its effects on the body’s own insulin production SAN DIEGO, Nov. […]

No Picture
San Diego Biotech Jobs

We can’t find this page

It looks like this page doesn’t exist or isn’t available right now. Check the URL for any… Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Reflow Medical Reports One-Year Results from DEEPER CORONARY Study of Investigational Coronary Spur® Elute Sirolimus-Eluting Retrievable Stent System

SAN CLEMENTE, Calif.–(BUSINESS WIRE)– #TCT2026–Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the presentation of one-year clinical results from the first-in-human DEEPER CORONARY study at Transcatheter Cardiovascular Therapeutics […]

No Picture
News

Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study Results

SAN DIEGO–(BUSINESS WIRE)– #PressRelease–Johnson & Johnson announced results from three clinical analyses being presented during the Transcatheter Cardiovascular Therapeutics annual scientific symposium (TCT 2026) that report positive survival and patient outcomes data when Impella™ heart […]


ADVERTISEMENT — Advertise With Biotech Networks